BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36047093)

  • 21. [POEMS syndrome. An interdisciplinary clinical challenge].
    Braun SA; Albrecht P; Methner A; Hanneken S
    Hautarzt; 2011 Oct; 62(10):722-5. PubMed ID: 21915731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Daratumumab plus lenalidomide and dexamethasone for relapsed POEMS syndrome with bone plasmacytoma harboring 17p deletion.
    Oyama T; Taoka K; Chiba A; Masamoto Y; Ikemura M; Honda A; Maki H; Kurokawa M
    Int J Hematol; 2023 Mar; 117(3):463-467. PubMed ID: 36202948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effective treatment of POEMS syndrome accompanied by plasmacytoma with lenalidomide, dexamethasone, and local irradiation].
    Takahashi W; Ichikawa M; Okazaki A; Nakamura F; Arai H; Handa T; Nakamura Y; Nakamura Y; Seo S; Sasaki K; Mitani K
    Rinsho Ketsueki; 2020; 61(3):262-267. PubMed ID: 32224588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lenalidomide-Induced Ischemic Cerebrovascular Disease in Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome.
    Mitsutake A; Matsumoto H; Hatano K; Irie K; Tsukada N; Hashida H
    J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):e102-e103. PubMed ID: 29395638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. POEMS syndrome: the matter-of-fact approach.
    Scarlato M; Previtali SC
    Curr Opin Neurol; 2011 Oct; 24(5):491-6. PubMed ID: 21677582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. POEMS syndrome: diagnostic delay and successful treatment with lenalidomide, cyclophosphamide and prednisone followed by autologous peripheral stem cell transplantation.
    Ordway S; Gilbert L; Wanko S
    BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 30054320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [POEMS syndrome: Diagnosis, stratification, treatments].
    Talbot A; Jaccard A; Arnulf B
    Rev Med Interne; 2021 May; 42(5):320-329. PubMed ID: 33678446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autologous cytokine-induced killer (CIK) cell immunotherapy combined with cyclophosphamide in five patients with POEMS syndrome.
    Ma L; Wang Y; Bo J; Han W; Wang Y; Zhang L; Wu X; Yu S; Liu R
    Clin Exp Immunol; 2016 Apr; 184(1):83-9. PubMed ID: 26660736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice.
    Minarik J; Pika T; Radocha J; Jungova A; Straub J; Jelinek T; Pour L; Pavlicek P; Mistrik M; Brozova L; Krhovska P; Machalkova K; Jindra P; Spicka I; Plonkova H; Stork M; Bacovsky J; Capkova L; Sykora M; Kessler P; Stejskal L; Heindorfer A; Ullrychova J; Skacel T; Maisnar V; Hajek R
    BMC Cancer; 2021 Jan; 21(1):73. PubMed ID: 33451293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial.
    Misawa S; Sato Y; Katayama K; Nagashima K; Aoyagi R; Sekiguchi Y; Sobue G; Koike H; Yabe I; Sasaki H; Watanabe O; Takashima H; Nishizawa M; Kawachi I; Kusunoki S; Mitsui Y; Kikuchi S; Nakashima I; Ikeda S; Kohara N; Kanda T; Kira J; Hanaoka H; Kuwabara S;
    Lancet Neurol; 2016 Oct; 15(11):1129-37. PubMed ID: 27496680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polyneuropathy, organomegaly, endocrinopathy, monoclonal band, and skin (POEMS) changes syndrome presenting with a pseudosensory level: a case report.
    Paranavitane S; Gooneratne L; Chang T
    J Med Case Rep; 2019 Dec; 13(1):384. PubMed ID: 31878962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lenalidomide as frontline therapy in polyneuropathy, organomegaly, endocrinopathy, monoclonal protein and skin changes syndrome: a retrospective case series of eight patients.
    Lestang E; Caristan A; NĂ©el A; Graveleau J; Duhamel E; Masseau A; Connault J; Maisonneuve H; Le Gouill S; Blin N; Touzeau C; Moreau P; Hamidou M
    Leuk Lymphoma; 2015 Jun; 56(6):1895-6. PubMed ID: 25347429
    [No Abstract]   [Full Text] [Related]  

  • 33. Polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes syndrome with dilated cardiomyopathy: A case report.
    Li JR; Feng LY; Li JW; Liao Y; Liu FQ
    World J Clin Cases; 2024 Jan; 12(3):601-606. PubMed ID: 38322456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of novel agents in patients with nephropathy associated with POEMS syndrome.
    Cheng S; Huang L; Fan W; Liang D; Zhu X; Jiang S; Ge Y
    Int Urol Nephrol; 2022 Sep; 54(9):2317-2325. PubMed ID: 35133575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ixazomib, lenalidomide, and dexamethasone combination in "real-world" clinical practice in patients with relapsed/refractory multiple myeloma.
    Sokol J; Guman T; Chudej J; Hlebaskova M; Stecova N; Valekova L; Kucerikova M; Stasko J
    Ann Hematol; 2022 Jan; 101(1):81-89. PubMed ID: 34550463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. POEMS Syndrome Showing Left Ventricular Dysfunction and Extracellular Edema Assessed by Cardiac Magnetic Resonance Imaging.
    Takahashi Y; Iwano H; Nakano I; Fukushima A; Naya M; Shimizu A; Matsuno Y; Oyama-Manabe N; Anzai T
    Intern Med; 2019 Sep; 58(17):2539-2543. PubMed ID: 31118405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and Safety of Regimens Used for the Treatment of POEMS Syndrome- A Systematic Review.
    Faizan U; Sana MK; Farooqi MS; Hashmi H
    Clin Lymphoma Myeloma Leuk; 2022 Jan; 22(1):e26-e33. PubMed ID: 34507924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pachymeningeal involvement in POEMS syndrome: dramatic cerebral MRI improvement after lenalidomide therapy.
    Briani C; Manara R; Lessi F; Citton V; Zambello R; Adami F
    Am J Hematol; 2012 May; 87(5):539-41. PubMed ID: 22389216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Skin Changes in POEMS Syndrome].
    Kuwabara S
    Brain Nerve; 2019 Apr; 71(4):350-353. PubMed ID: 30988219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The efficacy and safety profile of ixazomib/lenalidomide/dexamethasone in relapsed/refractory multiple myeloma: a multicenter real-world study in China].
    Yang Y; Xia ZJ; Zhang WH; Fu CC; Bao L; Chen B; Ding KY; Wang SL; Luo J; Li BZ; Hua LM; Yang W; Zhou X; Wang L; Xu TH; Wang WD; Wu GL; Huang Y; Li J; Liu P
    Zhonghua Xue Ye Xue Za Zhi; 2021 Aug; 42(8):628-634. PubMed ID: 34547867
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.